Despite substantial progress in reducing the global impact of many non-communicable
diseases, including heart disease and cancer, morbidity and mortality due to chronic respiratory …

Objective To determine whether or not radiofrequency ablation (RFA) for persistent atrial
fibrillation in patients with advanced heart failure leads to improvements in cardiac function. …

… Nathaniel M. Hawkins … Hawkins, John R. Petrie, Miles Fisher, Robert McKelvie, David
Aguilar, Henry Krum, John JV McMurray, Diabetes, left ventricular systolic dysfunction, and chronic …

Aims Socioeconomic status (SES) is a powerful predictor of incident coronary disease and
adverse cardiovascular outcomes. Understanding the impact of SES on heart failure (HF) …

Cardiac resynchronization therapy (CRT) markedly reduces morbidity and mortality in patients
with heart failure and prolonged QRS duration. Landmark trials have included over 4000 …

Chronic obstructive pulmonary disease (COPD) is a global health issue with high social and
economic costs. Concomitant chronic cardiac disorders are frequent in patients with COPD, …

Examination of patients with reduced and preserved ejection fraction in the DIG (Digitalis
Investigation Group) trials and the CHARM (Candesartan in Heart Failure: Assessment of …

Pulmonary disease is common in patients with heart failure, through shared risk factors and
pathophysiological mechanisms. Adverse pulmonary vascular remodelling and chronic …

The combination of heart failure and chronic obstructive pulmonary disease presents many
therapeutic challenges. The cornerstones of therapy are beta-blockers and beta-agonists, …

Aims Chronic obstructive pulmonary disease is an independent predictor of mortality in
patients with myocardial infarction (MI). However, the impact on mode of death and risk of …